Published 21 June 2017 Last updated 1 March 2021 + show all updates 1 March 2021 Added link to Oxford University video on weight management referrals. 21 June 2017 First published. Source link
COVID-19 patients are to receive second life-saving treatment for hospitalised patients outside of intensive care Thousands more lives could be saved as UK clinical trials show tocilizumab reduced the risk of death by 14% for patients on oxygen on top of benefits from dexamethasone Treatment will help reduce pressures on hospitals and improve outcomes for patientsThousands more NHS patients who are hospitalised due to COVID-19 will be able to receive life-saving treatment tocilizumab, the government has announced.The drug reduced the relative risk of death by 14% and reduced the time spent in hospital by 5 days when used for patients on oxygen and in addition to the corticosteroid…
AI imaging database will improve diagnosis of patients presenting with COVID-19 symptoms Increased speed and accuracy in diagnosis can lead to early medical intervention and save livesNHSX, a unit tasked with driving the digital transformation of care in the NHS, has brought together over 40,000 CT scans, MRIs and X-rays from more than 10,000 patients across the UK during the course of the pandemic.Access to this National COVID-19 Chest Imaging Database (NCCID) has now been extended to hospitals and universities across the country who are using the images to track patterns and markers of illness. The database can speed up diagnosis of COVID-19, leading to a quick treatment…
Patients in intensive care units across the UK are to receive potentially life-saving treatments for COVID-19 Government ensures life-saving drugs will be available in NHS healthcare settings with immediate effectPatients across the UK who are admitted to intensive care units due to COVID-19 are set to receive new life-saving treatments which can reduce the time spent in hospital by up to 10 days, the government has announced today (Thursday 7 January).Results from the government-funded REMAP-CAP clinical trial published today showed tocilizumab and sarilumab reduced the relative risk of death by 24%, when administered to patients within 24 hours of entering intensive care.Most of the data came from when…
Published 9 April 2020 Last updated 18 December 2020 + show all updates 18 December 2020 Updated to include information on designated settings and exemption from re-testing. 30 July 2020 Changes to self-isolation policy for all admitted patients to 14 days; updated section 3 to include the provision of written instructions for ongoing isolation when discharging patients. 20 May 2020 Updated guidance (all sections). 23 April 2020 Added clarifications of testing capacity and strategy and re-ordered the page for improved readability. 18 April 2020 Clarified text and reordered sections. 9 April 2020 First published. Source link
Seasonal flu vaccine uptake in GP patients: provisional monthly data for 1 September 2020 to 31 October 2020 by Region and STP ODS, 257KB This file is in an OpenDocument format This file may not be suitable for users of assistive technology. Request an accessible format. If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use. Seasonal flu vaccine uptake in GP patients: provisional monthly data for 1 September 2020 to 31 October 2020…
Cancer survival statistics for adults and children by stage at diagnosis and by different geographical variations. Source link
Published 12 August 2015 Last updated 28 September 2020 + show all updates 28 September 2020Added this year's invitation letter. 3 July 2019Added the new season template letter. 22 August 2018Added revised flu vaccination letter for at-risk patients. 12 July 2017Revised GP letter template for at risk patients. 12 July 2016Updated for 2016 to 2017 flu season. 12 August 2015First published. Source link
Published 4 April 2020 Last updated 28 September 2020 + show all updates 28 September 2020Updated the exemption of PCR retesting period from 6 weeks to 90 days. 18 August 2020Updates made to section 4 to include guidance on when health and social care staff can be exempt from being considered a contact for the purposes of Test and Trace. 31 July 2020Updated flowcharts to reflect the extension of the self-isolation period from 7 to 10 days. 30 July 2020Updated to reflect the extension of the self-isolation period from 7 days to 10 days for staff who have COVID-19 symptoms or a positive test result from the community; 14…
This report reviews data between 2014 and 2017 on patient doses from all types of dental X-ray imaging procedures including: intra oral panoramic cephalometric cone beam CT (CBCT) Public Health England and its predecessor organisations have carried out national reviews of patient dose indices at regular intervals for more than 20 years. The last review of radiographic and fluoroscopic imaging procedures in 2010 formed the basis of the current UK National Diagnostic Reference Levels (NDRLs) for these applications. This new review is necessary to either confirm that the existing NDRLs are still suitable or to set new values. Source link